// App-Quantinova.ai

1015 : Tracking evolution of aromatase inhibitor resistance with circulating tumour DNA (ctDNA) in metastatic breast cancer.

Researchers

Presenter

  • Charlotte Victoria Fribbens

Principal Investigators

  • Isaac Garcia-Murillas

  • Matthew Beaney

  • Sarah Hrebien

  • Karen Howarth

  • Michael Epstein

  • Nitzan Rosenfeld

  • Alistair E. Ring

  • Stephen R. D. Johnston

  • Nicholas C. Turner

Medical Centers

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

  • Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom

  • Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom

  • Inivata, Cambridge, United Kingdom

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

Locations

  • United Kingdom

Companies

  • Inivata Ltd

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Estrogen Receptor 1

  • Circulating DNA

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved